Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, March 2 2015 6:10pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Delivery News
Latest News
Monday, Mar 2, 2015
·Salix swings to much-wider-than-expected loss as sales plummet
at MarketWatch - 1 hour, 52 minutes ago
·Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results
Marketwire - 1 hour, 55 minutes ago
·Delcath To Present At The 27th Annual Roth Conference
PR Newswire - Mon 8:30 am ET
·Alkermes Announces New Drug Candidate, ALKS 7119, for Treatment of Alzheimer’s Agitation, Depression and Other CNS Diseases
Business Wire - Mon 7:00 am ET
Friday, Feb 27, 2015
·Aradigm Corporation President & CEO Dr. Igor Gonda, Ph.D. to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios - 640 WGST AM's "Health Tech Talk Live"
Marketwire - Fri Feb 27
Thursday, Feb 26, 2015
·Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015
PR Newswire - Thu Feb 26
Wednesday, Feb 25, 2015
·Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target
- Wed Feb 25
·Highline Research Advisors Initiates on Columbia Laboratories, Inc. with a Buy Rating
Thomson Reuters ONE - Wed Feb 25
·Top Growth Funds: Large Caps Making Inroads
at Investor's Business Daily, Inc. - Wed Feb 25
·PROVENGE® (sipuleucel-T) Demonstrates Sustained Immune Response Two Years after Treatment in Biochemically-Recurrent Prostate Cancer
PR Newswire - Wed Feb 25
·PROVENGE® (sipuleucel-T) Demonstrates Sustained Immune Response Two Years after Treatment in Biochemically-Recurrent Prostate Cancer
CNW Group - Wed Feb 25
Tuesday, Feb 24, 2015
·Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity
- Tue Feb 24
·Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care Conference
Business Wire - Tue Feb 24
·Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Salix Pharmaceuticals, Ltd.
Business Wire - Tue Feb 24
·Firms Bullish On Valeant Following Earnings, Acquisition
- Tue Feb 24
·Alkermes shares down after it stops development of pain pill
at bizjournals.com - Tue Feb 24
·Valeant Pharmaceuticals (VRX) Stock Higher Today as Analyst Increases Price Target on Salix Deal
at TheStreet.com - Tue Feb 24
·Alkermes beats Street 4Q forecasts
AP - Tue Feb 24
·Jim Cramer: Use Share Weakness to Buy Alkermes for Its Drug Pipeline
at TheStreet.com - Tue Feb 24
·Valeant Pharmaceuticals (VRX) Earnings Report: Q4 2014 Conference Call Transcript
at TheStreet.com - Tue Feb 24
More Latest News...
Sponsor Results
HRP-Based Antibody Arrays
HRP label-based antibody arrays. High sensitivity, many targets!
www.raybiotech.com
United Science QuEChERS
A Better Way to Recover your Planar Pesticides. No Toluene. No kidding.
uniscicorp.com
3DOF Orientation Tracker
Small accurate IMU for 3D measurement of human body segments and more.
xsens.com/mems
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?